ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-GP130 Antibody [B-R3] (A341850)

Mouse monoclonal [B-R3] IVD antibody to GP130 for IHC and Flow Cytometry.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 10-14 business days.
Name
Anti-GP130 Antibody [B-R3]
Description
Mouse monoclonal [B-R3] IVD antibody to GP130.
Specificity
This product recognizesGp130, common subunit for IL-6, IL-11, OSM, LIF, CNTF, CT-1 receptors, a 130-140 kDa protein.
Applications
IHC, Flow Cytometry
Reactivity
Human
Immunogen
Natural soluble gp130.
Host
Mouse
Clonality
Monoclonal
Clone ID
B-R3
Myeloma
Source: Myeloma X63/AG.8653 x Balb/c spleen cells
Isotype
Mouse IgG2a Kappa light chain
Conjugate

Unconjugated

Product Form
Liquid
Formulation
Phosphate-buffered saline with 1% BSA and 0.09% sodium azide.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
Intended Use
Use 10 µl to label 106 cells or 100 µl of whole blood.
General Notes
For bulk or custom IVD raw material requests, contact us directly.

IVD reagents are supplied in accordance with standard industry lead times of 4-6 weeks. Where products are in stock, dispatch typically occurs within 7-10 business days.
Synonyms
CD130, CDw130, IL-6 receptor subunit beta, IL-6R subunit beta, IL-6R-beta, IL-6RB, IL6ST, Interleukin-6 receptor subunit beta, Interleukin-6 signal transducer, Membrane glycoprotein 130, Oncostatin-M receptor subunit alpha
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-GP130 Antibody [B-R3] (A341850)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-GP130 Antibody [B-R3] (A341850)

Proteins predicted to interact with GP130

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.8% Relevancy Score
99.8% Relevancy Score
99.7% Relevancy Score
99.7% Relevancy Score
99.6% Relevancy Score